NCT04070664 is a clinical trial in Vertigo, Peripheral, sponsored by Ankara City Hospital Bilkent.

Who is sponsoring NCT04070664?

NCT04070664 is sponsored by Ankara City Hospital Bilkent.

What condition does NCT04070664 study?

NCT04070664 studies Vertigo, Peripheral, Vertigo, Central Origin, Oxidative Stress, Diagnosis.

Is NCT04070664 still recruiting?

NCT04070664 is currently completed. Last updated 28 August 2019.

Last reviewed 2019-08-28 · How we verify

NCT04070664

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thiol/Disulphide Homeostasis and Albumin in Vertigo

Completed Last updated 28 August 2019

What this trial tests

trial in Vertigo, Peripheral in 55 participants. Completed in 31 December 2018.

Timeline

1 July 2018

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Ankara City Hospital Bilkent
Status	Completed
Study type	OBSERVATIONAL
Enrollment	55
Start date	1 July 2018
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Turkey (Türkiye)

Conditions studied

Vertigo, Peripheral — all drugs for Vertigo, Peripheral →
Vertigo, Central Origin — all drugs for Vertigo, Central Origin →
Oxidative Stress — all drugs for Oxidative Stress →
Diagnosis — all drugs for Diagnosis →

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 51 to 85, any sex, with Vertigo, Peripheral or Vertigo, Central Origin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vertigo is a common complaint in the Emergency Department (ED). The differential diagnosis of central and peripheral vertigo is a difficult issue that directly affects mortality. Magnetic resonance imaging (MRI) is the preferred diagnostic tool, but may not be suitable in all patients due to logistic and economic conditions. In this study, the investigators evaluated the role of thiol/disulfide homeostasis (TDH) parameters and ischemia modified albumin (IMA) levels to assist in the value of being used instead of MRI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Vertigo, Peripheral

Currently open trials in the same condition.

NCT06228196 — Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China · recruiting

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04070664 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
Last refreshed: 28 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04070664.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing